ATE551341T1 - Chinuklidincarbonatderivate und medizinische zusammensetzung davon - Google Patents

Chinuklidincarbonatderivate und medizinische zusammensetzung davon

Info

Publication number
ATE551341T1
ATE551341T1 AT09777321T AT09777321T ATE551341T1 AT E551341 T1 ATE551341 T1 AT E551341T1 AT 09777321 T AT09777321 T AT 09777321T AT 09777321 T AT09777321 T AT 09777321T AT E551341 T1 ATE551341 T1 AT E551341T1
Authority
AT
Austria
Prior art keywords
medical composition
carbonate derivatives
quinuclidine
quinuclidine carbonate
derivatives
Prior art date
Application number
AT09777321T
Other languages
English (en)
Inventor
Gabriele Amari
Maurizio Delcanale
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Application granted granted Critical
Publication of ATE551341T1 publication Critical patent/ATE551341T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT09777321T 2008-08-08 2009-07-21 Chinuklidincarbonatderivate und medizinische zusammensetzung davon ATE551341T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08162066A EP2154136A1 (de) 2008-08-08 2008-08-08 Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
PCT/EP2009/005272 WO2010015324A1 (en) 2008-08-08 2009-07-21 Quinuclidine carbonate derivatives and medicinal composition thereof

Publications (1)

Publication Number Publication Date
ATE551341T1 true ATE551341T1 (de) 2012-04-15

Family

ID=40228074

Family Applications (1)

Application Number Title Priority Date Filing Date
AT09777321T ATE551341T1 (de) 2008-08-08 2009-07-21 Chinuklidincarbonatderivate und medizinische zusammensetzung davon

Country Status (31)

Country Link
US (3) US8039483B2 (de)
EP (2) EP2154136A1 (de)
JP (1) JP2011530489A (de)
KR (1) KR20110044221A (de)
CN (1) CN102112474B (de)
AR (1) AR072994A1 (de)
AT (1) ATE551341T1 (de)
AU (1) AU2009278306B2 (de)
CA (1) CA2733380A1 (de)
CO (1) CO6351790A2 (de)
CY (1) CY1112724T1 (de)
DK (1) DK2313404T3 (de)
EA (1) EA019166B1 (de)
ES (1) ES2384914T3 (de)
GE (1) GEP20135744B (de)
HR (1) HRP20120394T1 (de)
IL (1) IL211103A (de)
JO (1) JO2831B1 (de)
MA (1) MA32622B1 (de)
ME (1) ME01283A (de)
MX (1) MX2011001504A (de)
MY (1) MY156332A (de)
NZ (1) NZ590987A (de)
PL (1) PL2313404T3 (de)
PT (1) PT2313404E (de)
RS (1) RS52370B (de)
SI (1) SI2313404T1 (de)
TW (1) TWI455938B (de)
UA (1) UA102857C2 (de)
WO (1) WO2010015324A1 (de)
ZA (1) ZA201100963B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2534957B1 (de) 2007-12-14 2015-05-27 AeroDesigns, Inc Abgabe von Aerosol-sprühbaren Produkten
EP2154136A1 (de) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
EP2206712A1 (de) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. Alkaloidaminoester-Derivate und medizinische Zusammensetzung davon
RU2580312C2 (ru) 2010-04-21 2016-04-10 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Способ получения частиц с пониженным электростатическим зарядом
WO2011160919A1 (en) 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Alkaloid aminoester derivatives and medicinal composition thereof
KR20130111968A (ko) 2010-06-22 2013-10-11 키에시 파르마슈티시 엣스. 피. 에이. 알칼로이드 아미노에스테르 유도체 및 이의 의약 조성물
CA2803459A1 (en) 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Alkaloid aminoester derivatives and medicinal compositions thereof
WO2012041717A1 (en) * 2010-09-30 2012-04-05 Chiesi Farmaceutici S.P.A. Use of magnesium stearate in dry powder formulations for inhalation
CN103168038A (zh) * 2010-10-20 2013-06-19 奇斯药制品公司 用于治疗咳嗽的碳酸酯衍生物
KR20130141534A (ko) 2010-11-26 2013-12-26 키에시 파르마슈티시 엣스. 피. 에이. 글리신 유도체 및 무스카린 수용체 길항제로서의 이들의 용도
LT2685986T (lt) * 2011-03-18 2020-03-10 Genzyme Corporation Gliukozilceramido sintazės slopiklis
RU2611627C2 (ru) * 2011-04-29 2017-02-28 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Алкалоидный эфир и карбаматные производные и их медицинские композиции
KR20140105746A (ko) 2011-12-30 2014-09-02 키에시 파르마슈티시 엣스. 피. 에이. 항무스카린제로서 1-아자헤테로시클릴아세트산의 퀴누클리딘 에스터, 이들의 제조 방법 및 이들의 의약 조성물
MA37975B2 (fr) * 2012-09-11 2021-03-31 Genzyme Corp Inhibiteurs de synthase de glucosylcéramide
US9427376B2 (en) 2013-10-10 2016-08-30 Chiesi Farmaceutici S.P.A. Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient
PT3920912T (pt) 2019-02-04 2025-09-09 Genzyme Corp Tratamento de ciliopatias usando inibidores da glucosilceramida sintase (gcs)
IL295255A (en) 2020-02-03 2022-10-01 Genzyme Corp Methods for treating neurological symptoms associated with lysosomal storage diseases
IL300090A (en) 2020-07-24 2023-03-01 Genzyme Corp Pharmaceutical preparations containing VENGLUSTAT

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
EP1345937B1 (de) 2000-12-22 2005-09-28 Almirall Prodesfarma AG Chinuclidincarbamat derivate und deren verwendung als m3 antagonisten
CA2443346A1 (en) * 2001-04-03 2002-12-05 Aryx Therapeutics Anticholinergic compounds and methods of use
CA2470956C (en) 2001-12-20 2011-08-02 Laboratorios S.A.L.V.A.T., S.A. 1-alkyl-1-azoniabicyclo[2.2.2]octane carbamate derivatives and their use as muscarinic receptor antagonists
EP1882691A1 (de) * 2006-07-26 2008-01-30 CHIESI FARMACEUTICI S.p.A. Chinuclidinderivate als M3 Antagonisten
EP2154136A1 (de) 2008-08-08 2010-02-17 CHIESI FARMACEUTICI S.p.A. Chinuclidin-Carbonat-Derivate und medizinische Zusammensetzungen damit
EP2206712A1 (de) 2008-12-23 2010-07-14 CHIESI FARMACEUTICI S.p.A. Alkaloidaminoester-Derivate und medizinische Zusammensetzung davon
CA2803418A1 (en) 2010-06-22 2011-12-29 Chiesi Farmaceutici S.P.A. Dry powder formulation comprising an antimuscarinic drug
CN103168038A (zh) 2010-10-20 2013-06-19 奇斯药制品公司 用于治疗咳嗽的碳酸酯衍生物
US20120220557A1 (en) 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
RU2611627C2 (ru) 2011-04-29 2017-02-28 КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. Алкалоидный эфир и карбаматные производные и их медицинские композиции

Also Published As

Publication number Publication date
MY156332A (en) 2016-02-15
RS52370B (sr) 2012-12-31
HRP20120394T1 (hr) 2012-06-30
CN102112474B (zh) 2014-01-29
EP2154136A1 (de) 2010-02-17
UA102857C2 (en) 2013-08-27
ME01283A (me) 2013-06-20
SI2313404T1 (sl) 2012-07-31
HK1156032A1 (en) 2012-06-01
US20110319444A1 (en) 2011-12-29
MA32622B1 (fr) 2011-09-01
US8404712B2 (en) 2013-03-26
GEP20135744B (en) 2013-02-11
AR072994A1 (es) 2010-10-06
US20100035922A1 (en) 2010-02-11
AU2009278306A1 (en) 2010-02-11
KR20110044221A (ko) 2011-04-28
EA019166B1 (ru) 2014-01-30
CA2733380A1 (en) 2010-02-11
JP2011530489A (ja) 2011-12-22
IL211103A (en) 2014-04-30
CN102112474A (zh) 2011-06-29
TW201011022A (en) 2010-03-16
NZ590987A (en) 2012-11-30
MX2011001504A (es) 2011-03-29
DK2313404T3 (da) 2012-06-04
EA201100161A1 (ru) 2011-10-31
WO2010015324A1 (en) 2010-02-11
AU2009278306B2 (en) 2014-06-26
IL211103A0 (en) 2011-04-28
EP2313404A1 (de) 2011-04-27
US20120004258A1 (en) 2012-01-05
JO2831B1 (en) 2014-09-15
US8440690B2 (en) 2013-05-14
PT2313404E (pt) 2012-07-02
PL2313404T3 (pl) 2012-09-28
CO6351790A2 (es) 2011-12-20
US8039483B2 (en) 2011-10-18
ZA201100963B (en) 2012-05-30
TWI455938B (zh) 2014-10-11
ES2384914T3 (es) 2012-07-13
CY1112724T1 (el) 2016-02-10
EP2313404B1 (de) 2012-03-28

Similar Documents

Publication Publication Date Title
DK2313404T3 (da) Quinuclidin-carbonat-derivater og medicinsk sammensætning deraf
BRPI0918206A2 (pt) derivados de animoéster e composição medicinal destes
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI1011587A2 (pt) compostos e composições terapèuticas
PT2567707T (pt) Composição de péptidos associados a tumores e vacina anticancro relacionada
BRPI0906980A2 (pt) Composição de derivados e maleatados
ATE488227T1 (de) Feste zubereitung mit alogliptin und pioglitazon
BR112012001532A2 (pt) "substituída azolesulfonamides benzoimid e indolesulfonamides substituído como potenciadores mglur4"
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
BRPI0819232A2 (pt) composto heterocíclico e composição farmacêutica do mesmo
BRPI0905369A2 (pt) Composição farmacêutica, composição e kit compartimentado
EP2236149A4 (de) Medizinische zusammensetzung
DE602008001981D1 (de) Stellung und therapeutische verwendung
EP2144635A4 (de) Sterilisierende zusammensetzung
DK2391349T3 (da) Farmaceutisk sammensætning omfattende 2-oco-1-pyrrolidin-derivater
EP2298365A4 (de) Medizinische zusammensetzung und medizinisches kit
EP2335669A4 (de) Zusammensetzung für ein mittel zur desensibilisierung der zähne
DK2285413T3 (da) Farmaceutisk sammensætning
DK2391351T3 (da) Farmaceutisk sammensætning omfattende 2-oxo-1-pyrrolidinderivater
ATE536893T1 (de) Zibotentan zusammensetzung mit mannitol und mikrokristalliner zellulose
BRPI0921313A2 (pt) composição farmaucêutica
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI1006953A2 (pt) composição farmacêutica, e, uso de uma composição
ATE499368T1 (de) Chinolonverbindung und pharmazeutische zusammensetzung